Archivio istituzionale della ricerca dell'Università degli Studi di Palermo

POMA, Paola
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.695
EU - Europa 4.619
AS - Asia 3.688
SA - Sud America 654
Continente sconosciuto - Info sul continente non disponibili 488
AF - Africa 128
OC - Oceania 3
Totale 17.275
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.511
SG - Singapore 1.300
IT - Italia 1.205
RU - Federazione Russa 1.048
CN - Cina 884
BR - Brasile 533
FI - Finlandia 518
UA - Ucraina 384
HK - Hong Kong 379
DE - Germania 359
VN - Vietnam 354
PL - Polonia 214
IE - Irlanda 201
GB - Regno Unito 194
FR - Francia 175
BD - Bangladesh 145
JP - Giappone 137
IN - India 112
SE - Svezia 108
CA - Canada 84
TR - Turchia 82
KR - Corea 54
MX - Messico 46
AR - Argentina 41
NL - Olanda 40
IQ - Iraq 38
BE - Belgio 35
PK - Pakistan 29
ES - Italia 27
ZA - Sudafrica 26
MY - Malesia 25
VE - Venezuela 23
CI - Costa d'Avorio 22
MA - Marocco 21
AT - Austria 19
RO - Romania 18
UZ - Uzbekistan 17
EC - Ecuador 16
EG - Egitto 16
ID - Indonesia 16
IR - Iran 16
BG - Bulgaria 15
SA - Arabia Saudita 14
CH - Svizzera 12
CL - Cile 12
TN - Tunisia 12
AE - Emirati Arabi Uniti 10
CR - Costa Rica 10
CZ - Repubblica Ceca 10
JM - Giamaica 10
AZ - Azerbaigian 9
CO - Colombia 9
LT - Lituania 9
PH - Filippine 9
DZ - Algeria 8
HN - Honduras 7
KZ - Kazakistan 7
LB - Libano 7
TT - Trinidad e Tobago 7
KE - Kenya 6
SY - Repubblica araba siriana 6
UY - Uruguay 6
BH - Bahrain 5
GR - Grecia 5
AL - Albania 4
BB - Barbados 4
BO - Bolivia 4
JO - Giordania 4
MT - Malta 4
NP - Nepal 4
PA - Panama 4
PE - Perù 4
PS - Palestinian Territory 4
PY - Paraguay 4
TW - Taiwan 4
AU - Australia 3
ET - Etiopia 3
EU - Europa 3
GH - Ghana 3
GT - Guatemala 3
LY - Libia 3
NI - Nicaragua 3
OM - Oman 3
PR - Porto Rico 3
RS - Serbia 3
SN - Senegal 3
TH - Thailandia 3
AO - Angola 2
DK - Danimarca 2
GA - Gabon 2
GE - Georgia 2
GY - Guiana 2
KG - Kirghizistan 2
MN - Mongolia 2
NO - Norvegia 2
PT - Portogallo 2
AG - Antigua e Barbuda 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BQ - ???statistics.table.value.countryCode.BQ??? 1
Totale 16.779
Salva come PNG Salva come JPEG
Città #
Ashburn 900
Singapore 866
Fairfield 700
San Jose 489
Chandler 405
Houston 403
Woodbridge 373
Hong Kong 366
Palermo 344
Ann Arbor 331
Wilmington 297
Seattle 257
Cambridge 222
Jacksonville 209
Dublin 195
Zgierz 191
Moscow 172
Santa Clara 163
Beijing 154
Des Moines 141
Medford 136
Tokyo 130
Los Angeles 129
New York 127
Council Bluffs 124
Ho Chi Minh City 122
Frankfurt am Main 107
Dallas 97
Boardman 96
Nanjing 89
Lauterbourg 85
Princeton 85
Hanoi 79
The Dalles 76
Helsinki 73
Hefei 66
Altamura 62
Tulsa 56
Buffalo 54
São Paulo 52
San Diego 51
Lawrence 48
Dearborn 43
Milan 37
Rome 37
Izmir 33
Brussels 32
Venice 32
Atlanta 29
Nanchang 28
Shenyang 28
Chicago 27
Hebei 27
Ludwigshafen am Rhein 27
London 26
Bremen 25
Memphis 25
Brooklyn 23
Abidjan 22
Changsha 22
Columbus 22
Toronto 22
Rio de Janeiro 20
Shanghai 20
Denver 19
Jinan 19
Munich 19
Phoenix 19
Falls Church 18
Kuala Lumpur 18
Messina 17
Nuremberg 17
Orem 17
Montreal 16
Belo Horizonte 15
Hangzhou 15
Naples 15
Verona 15
Baghdad 14
Brasília 14
Jiaxing 14
Johannesburg 14
Ningbo 14
San Paolo di Civitate 14
Seongnam 14
Warsaw 14
Amsterdam 13
Catania 13
Kumar 13
San Francisco 13
Tashkent 13
Zhengzhou 13
Chennai 12
Da Nang 12
Guangzhou 12
Saint Petersburg 12
Sofia 12
Stockholm 12
Tianjin 12
Auburn Hills 11
Totale 10.253
Salva come PNG Salva come JPEG
Nome #
ANTITUMOR EFFECTS OF CURCUMIN, ALONE OR IN COMBINATION WITH CISPLATIN OR DOXORUBICIN, ON HUMAN HEPATIC CANCER CELLS. ANALYSIS OF THEIR POSSIBLE RELATIONSHIP TO CHANGES IN NF-KB ACTIVATION LEVELS AND IAP GENE EXPRESSION 318
Antitumor effects of curcumin and structurally beta-diketone modified analogs on multidrug resistant cancer cells 305
Chemical and pharmaceutical evaluation of the relationship between triazole linkers and pore size on cyclodextrin–calixarene nanosponges used as carriers for natural drugs 286
Antitumor mechanism of the essential oils from two succulent plants in multidrug resistance leukemia cell 286
Targeting Multiple Myeloma with natural polyphenols 284
Development and characterization of co-loaded curcumin/triazole-halloysite systems and evaluation of their potential anticancer activity. 269
Chemical Composition, In Vitro Antitumor and Pro-Oxidant Activities of Glandora rosmarinifolia (Boraginaceae) Essential Oil 269
"Antitumor effects of the novel NF-kB inhibitor dehydroxymethylepoxyquinomicin (DHMEQ) on human hepatic cancer cells: analysis of synergy with cisplatin and of possible correlation with inhibition of pro-survival genes and IL-6 production”. 256
Induction of Apoptosis and Chemosensitization by the Histone Deacetylase Inhibitor Trichostatin in Hepatocellular Carcinoma Cells: Molecular Analysis and RKIP Levels 254
Analysis of Possible Mechanisms Accounting for Raf-1 Kinase Inhibitor Protein Downregulation in Hepatocellular Carcinoma 252
Curcumin as a possible lead compound against hormone-independent, multidrug-resistant breast cancer 248
Epigenetic changes and nuclear factor-κB activation, but not microRNA-224, downregulate Raf-1 kinase inhibitor protein in triple‑negative breast cancer SUM 159 cells 248
Essential oil of Cyphostemma juttae (Vitaceae): chemical composition and antitumor mechanism in triple negative breast cancer cells 248
Frequent Alteration of the Yin Yang 1/Raf-1 Kinase Inhibitory Protein Ratio in Hepatocellular Carcinoma 246
Yin Yang 1 and Raf-1 Kinase Inhibitory Protein Status in Hepatocellular Carcinoma: Future Perspectives 237
The antitumor activities of curcumin and its isoxazole analogue are not affected by multiple gene expression changes in an MDR model of the MCF-7 brest cancer cell line: Analysis of the possible molecular basis. 231
Pharmaceutical properties of supramolecular assembly of co-loaded cardanol/triazole-halloysite systems 230
Expression of the IAPs in multidrug resistant tumor cells 228
Meccanismi antitumorali degli oli essenziali estratti da piante succulente in un modello di leucemia mielocitica acuta multifarmacoresistente 223
Pro-oxidant and antitumor effects of curcumin and N-ethylmaleimide in the HA22T/VGH model Overt hepatocellular carcinoma. 216
Alteration of signaling pathways in hepatocellular carcinoma: identification of new pharmacological targets and possible prognosis markers. 216
Effetti della curcumina e di suoi analoghi modificati al frammento beta-dichetone in cellule tumorali multifarmacoresistenti. 215
Cytotoxicity of oleanolic and ursolic acid derivatives toward hepatocellular carcinoma and evaluation of NF-κB involvement 213
Frequent alteration of the Yin Yang 1/Raf-1 Kinase Inhibitory Protein ratio in hepatocellular carcinoma 209
Multifactorial nature of hepatocellular carcinoma drug resistance: Could plant polyphenols be helpful? 204
Essential Oil Composition of Alluaudia procera and in Vitro Biological Activity on Two Drug-Resistant Models 202
Direct chemical grafted curcumin on halloysite nanotubes as dual-responsive prodrug for pharmacological applications 201
Co-loaded cardanol/triazole-halloysite system: characterization of the supramolecular complex and evaluation of its antiproliferative activity 200
Can NF-κB Be Considered a Valid Drug Target in Neoplastic Diseases? Our Point of View 200
Mechanisms of Raf-1 Kinase Inhibitor Protein Dysregulation in Triple-Negative Breast Cancers and Identification of Possible Novel Therapeutic Approaches for These Tumors 198
Chemical and biological evaluation of cross-linked halloysite-curcumin derivatives 198
Induction of apoptosis and inhibition of cell growth in human hepatocellular carcinoma cells by COX-2 inhibitors 193
Analysis of UGT1A1*28 and DPYD*2A polymorphisms in Sicilians patients with metastatic colorectal cancer treated with Irinotecan and 5-fluorouracil. 191
Induction of apoptosis by the proteasome inhibitor MG132 in human HCC cells: Possible correlation with specific caspase-dependent cleavage of β-catenin and inhibition of β-catenin-mediated transactivation 189
The effect of CYP3A5 and ABCB1 single nucleotide polymorphisms on tacrolimus dose requirements in Caucasian liver transplant patients 188
Citrus wastewater as a source of value‐added products: Quali‐quantitative analysis and in vitro screening on breast cancer cell lines 187
Antitumor effects of the grape stilbenes resveratrol and piceatannol on multidrug and apoptosis resistant HL60 leukemia cells" 186
Antitumor effects of the NF-kB inhibitors curcumin and DHMEQ, alone or combined with cisplatin, on hepatic cancer cells. analysis of their relationship to IL-6 production. 185
Unusual high dose of tacrolimus in liver transplant patient, a case report. 185
Antitumor effects of curcumin, alone or in combination with cisplatin, on hepatic cancer cells. Analysis of their relationship to IL-6 production 182
The NF-kB inhibitors curcumin and DHMEQ exert antitumor synergy with cisplatin in hepatic cancer cells. Analysis of relationship to IL-6 production. 180
Antitumor effects of curcumin in human hepatic cancer cells: Analysis of their relationship to inhibition of NF-kB and pro-survival gene expression. 179
Influence of CYP3A5 and ABCB1 gene polymorphisms and other factors on tacrolimus dosing in Caucasian liver and kidney transplant patients. 179
Apollon gene silencing induces apoptosis in breast cancer cells via p53 stabilisation and caspase-3 activation 178
Plant polyphenols as possible lead compound against hormone-independent multidrug resistant breast cancer. 172
Pharmacogenetic considerations for optimizing tacrolimus dosing in liver and kidney transplant patients 172
“Antitumor and molecular effects of curcumin and of its isoxazole analogue on multidrug resistant breast cancer cells. New perspectives in tumor theraphy: molecular aspects, 2006”. 170
Synthesis of Curcumin Derivatives and Analysis of Their Antitumor Effects in Triple Negative Breast Cancer (TNBC) Cell Lines 169
Analysis of pharmacologic approaches able to restore RKIP function in hepatocellular carcinoma 167
Phytol and heptacosane: the two major components of Euphorbia intisy essential oil with biological activities in drug resistant leukemia cell. 167
PLLA Porous Scaffold as a 3D Breast Cancer Model to Investigate Drug Resistance 166
NF-kB Is a Potential Molecular Drug Target in Triple-Negative Breast Cancers 166
Lack of nucleophilic addition in the isoxazole and pyrazole diketone modified analogs of curcumin; implications for their antitumor and chemosensitizing activities. 165
null 164
Caratterizzazione e valutazione dell’attività anti proliferativa di nuovi sistemi per il drug carrier Allosite-sali triazolici/cardanolo 164
Induction of apoptosis by the adenosine derivative IB-MECA in parental or multidrug-resistant HL-60 leukemia cells: possibile relationship to the effects on inhibitor of apoptosis protein levels 163
Antitumor Effect of Glandora rosmarinifolia (Boraginaceae) Essential Oil through Inhibition of the Activity of the Topo II Enzyme in Acute Myeloid Leukemia 163
Le attività antitumorali della curcumina e del suo più potente analogo isossazolico non sono compromesse dal pattern di espressione genica della variante MDR della linea di carcinoma mammario MCF-7 162
In Vitro Modulation of P-Glycoprotein Activity by Euphorbia intisy Essential Oil on Acute Myeloid Leukemia Cell Line HL-60R 160
Significance of Autologous Interleukin-6 Production in the HA22T/VGH Cell Model of Hepatocellular Carcinoma 159
DISTRIBUTION OF CYP3A5 AND MDR-1 SINGLE NUCLEOTIDE POLYMORPHISMS IN CAUCASIAN LIVER TRANSPLANT PATIENTS 156
Expression of IAPs (Inhibitory of Apoptosis Proteins) and of their alternative splice variants in hepatocellular carcinoma tissues and cells 155
Antitumor effects of curcumin and of its combination with cisplatin or doxorubicin on human hepatic cancer cells: possible relationship to NF-kB activation and IAP gene expression. 150
Potential Therapeutic Applications of MDA-9/Syntenin-NF-κB-RKIP Loop in Human Liver Carcinoma 150
Prodrug based on halloysite delivery systems to improve the antitumor ability of methotrexate in leukemia cell lines 147
Alteration of the YY1/RKIP ratio is a frequent event in hepatocellular carcinoma 146
Effetti della curcumina e del suo derivato isossazolico in modelli di neoplasia multifarmacoresistente 144
The antitumor activities of curcumin and of its novel isoxazole analogue MR 39 are not hampered by the multidrug resistant condition of tumor cells expressing both P-glycoprotein and different inhibitory of apoptosis proteins 144
SYNTHESIS AND CHARACTERIZATION OF POSITIVELY CHARGED FUNCTIONALIZED HALLOYSITE/CURCUMIN SYSTEMS AND EVALUATION OF THEIR ANTICANCER ACTIVITY 144
Rash and multiorgan dysfunction following lamotrigine: could genetic be involved? 144
ELABORATION OF CURCUMIN INTO DIKETONE MODIFIED ANALOGUES DEVOID OF NUCLEOPHILIC ADDITION CAPABILITY; IMPLICATIONS FOR THEIR ANTITUMOR AND CHEMOSENSITIZING ACTIVITIES 142
NF-κB is a potential pharmacological target in triple negative breast cancers. 139
Natural Inhibitors of P-glycoprotein in AcuteMyeloid Leukemia 139
Effects of curcumin and related analogues on tumor cell lines expressing multiple mechanisms of drug resistance 135
Antitumor effects of curcumin and of its combinations with cisplatin or doxorubicin on human hepatic cancer cells: Possible relationship to NF-kB activation and IAP gene expression 132
Antimigratory effects of a new NF-κB inhibitor, (S)-b-salicyloylamino-a-exo-methylene-ƴ-butyrolactone, in 2D and 3D breast cancer models 130
New trends in overcoming drug resistance in hepatocellular carcinoma. Looking for pharmacological inhibition of Inhibitory of Apoptosis Proteins (IAPs) by curcumin. 128
Possible mechanisms of Raf-1 Kinase Inhibitor Protein down-regulation in hepatocellular carcinoma 127
THE EFFECT OF CYP3A5 AND ABCB1 SINGLE NUCLEOTIDE POLYMORPHISMS ON TACROLIMUS DOSE REQUIREMENTS IN CAUCASIAN LIVER TRANSPLANT PATIENTS 127
Effects of the dietary polyphenols resveratrol and curcumin on the prevention and treatment of cancer. 122
Phytol and Heptacosane Are Possible Tools to Overcome Multidrug Resistance in an In Vitro Model of Acute Myeloid Leukemia 122
Vesicle-Transported Multidrug Resistance as a Possible Therapeutic Target of Natural Compounds 120
Epigenetic and Cellular Reprogramming of Doxorubicin-Resistant MCF-7 Cells Treated with Curcumin 120
Raf-1 Kinase Inhibitor Protein down-regulation in hepatocellular carcinoma: investigation of possible mechanisms 119
Inhibitor of apoptosis proteins (IAPs) as new possible therapeutic targets in hepatocellular cancer 115
Exploring the cellular uptake of hectorite clay mineral and its drug carrier capabilities 114
Ihnibitor of Apoptosis Proteins (IAPs) as a new possible therapeutic targets in hepatocellular cancer. 113
The selective COX-1 inhibitor SC-560 inhibits cell growth and induces apoptosis in human hepatocellular carcinoma cells 113
Restoration of Raf-1 Kinase Inhibitor Protein levels as a possible therapeutic approach in hepatocellular carcinoma. 113
Novel insights on [1,2]oxazolo[5,4‐e]isoindoles on multidrug resistant acute myeloid leukemia cell line 112
Synthesis, In Vitro and In Silico Analysis of New Oleanolic Acid and Lupeol Derivatives against Leukemia Cell Lines: Involvement of the NF-κB Pathway 110
A Curcumin-BODIPY Dyad and Its Silica Hybrid as NIR Bioimaging Probes 109
Curcumin and doxorubicin encapsulated in biocompatible clay‐based nanomaterial: A strategy to overcome multidrug resistance 108
Plant polyphenols as privileged multi-target compounds for chemo- and immuno-sensitization 98
NF-kB and Disease 97
MDA-9/Syntenin-NF-κB-RKIP loop in triple negative breast cancers (TNBC) and human liver carcinoma 94
Covalently Functionalized Halloysite-Calixarene Nanotubes for Injectable Hydrogels: A Multicavity Platform for Hydrophobic Drug Delivery 79
Patterns of Innate or Acquired Resistance to Anticancer Drugs: Our Experience to Overcome It 74
null 67
Altered Yin Yang 1/RAF-1 kinase inhibitory protein ratio as a possible molecular marker and therapeutic target in hepatocellular carcinoma 36
Totale 17.275
Salva come PNG Salva come JPEG
Categoria #
all - tutte 56.583
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 56.583
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.122 0 236 32 21 57 37 72 41 117 197 77 235
2022/20231.335 140 209 22 155 161 217 107 84 147 14 65 14
2023/2024692 50 98 50 27 38 137 48 48 14 36 40 106
2024/20252.152 43 185 111 193 124 82 196 141 189 226 238 424
2025/20266.453 426 204 381 511 569 959 895 631 430 839 287 321
2026/2027330 267 63 0 0 0 0 0 0 0 0 0 0
Totale 17.275